Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Interest & Investment Income: 2020-2024

Historic Interest & Investment Income for Avidity Biosciences (RNA) over the last 5 years, with Dec 2024 value amounting to $56.9 million.

  • Avidity Biosciences' Interest & Investment Income fell 17.94% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.9 million, marking a year-over-year increase of 42.85%. This contributed to the annual value of $56.9 million for FY2024, which is 137.29% up from last year.
  • As of FY2024, Avidity Biosciences' Interest & Investment Income stood at $56.9 million, which was up 137.29% from $24.0 million recorded in FY2023.
  • In the past 5 years, Avidity Biosciences' Interest & Investment Income ranged from a high of $56.9 million in FY2024 and a low of $104,000 during FY2021.
  • Its 3-year average for Interest & Investment Income is $28.6 million, with a median of $24.0 million in 2023.
  • Per our database at Business Quant, Avidity Biosciences' Interest & Investment Income plummeted by 49.51% in 2021 and then skyrocketed by 4,683.65% in 2022.
  • Avidity Biosciences' Interest & Investment Income (Yearly) stood at $206,000 in 2020, then tumbled by 49.51% to $104,000 in 2021, then skyrocketed by 4,683.65% to $5.0 million in 2022, then skyrocketed by 381.85% to $24.0 million in 2023, then surged by 137.29% to $56.9 million in 2024.